OSE Immunotherapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	18.01	16.75	18.67	25.62	33.58
Short-Term Investments	9.79	42.37	-	-	-
Cash & Short-Term Investments	27.81	59.12	18.67	25.62	33.58
Cash Growth	-52.96%	216.61%	-27.12%	-23.70%	14.34%
Accounts Receivable	-	4.17	1.15	0.4	0.77
Other Receivables	-	3.14	6.44	5.98	5.18
Receivables	-	7.31	7.59	6.39	5.95
Prepaid Expenses	-	2.29	2.75	3.45	2.96
Other Current Assets	8.05	1.22	1.47	1.74	1.72
Total Current Assets	35.86	69.93	30.48	37.2	44.21
Property, Plant & Equipment	0.4	3.43	4.07	4.98	5.44
Long-Term Investments	6.25	5.05	-	-	-
Other Intangible Assets	43.2	0.11	0.14	0.17	0.15
Long-Term Deferred Tax Assets	-	0.19	0.2	0.18	0.17
Long-Term Deferred Charges	-	43.9	46.26	48.62	50.97
Other Long-Term Assets	-1.49	1.36	0.91	0.64	0.94
Total Assets	84.22	123.96	82.05	91.78	101.88
Accounts Payable	8.11	7.72	9.3	8.54	9.61
Accrued Expenses	-	-	-	2.92	3.72
Current Portion of Long-Term Debt	11.98	7.2	6.4	3.09	1.61
Current Portion of Leases	-	0.6	0.86	0.88	0.76
Current Income Taxes Payable	-	2.67	1.89	0.02	0.01
Current Unearned Revenue	-	2.03	0.35	0.81	1.05
Other Current Liabilities	3.26	0	0.01	0	0
Total Current Liabilities	23.35	20.22	18.8	16.27	16.76
Long-Term Debt	23.68	35.66	35.51	37.23	30.8
Long-Term Leases	-	2.68	3.03	3.59	3.97
Long-Term Unearned Revenue	-	0.1	-	-	-
Pension & Post-Retirement Benefits	-	0.42	0.43	0.43	0.42
Long-Term Deferred Tax Liabilities	1.07	1.07	1.31	1.51	1.75
Other Long-Term Liabilities	2.6	-	-	0.09	0.29
Total Liabilities	50.7	60.15	59.08	59.12	53.99
Common Stock	33.52	4.39	4.33	3.71	3.71
Additional Paid-In Capital	-	77.74	76.64	65.61	65.61
Retained Earnings	-	37.45	-23	-17.76	-16.85
Treasury Stock	-	-0.45	-0.41	-0.55	-0.16
Comprehensive Income & Other	-	-55.32	-34.59	-18.35	-4.41
Shareholders' Equity	33.52	63.81	22.98	32.66	47.89
Total Liabilities & Equity	84.22	123.96	82.05	91.78	101.88
Total Debt	35.66	46.13	45.8	44.79	37.13
Net Cash (Debt)	-7.85	12.99	-27.13	-19.17	-3.55
Net Cash Per Share	-0.36	0.51	-1.39	-1.03	-0.20
Filing Date Shares Outstanding	22	22.31	21.59	18.45	18.49
Total Common Shares Outstanding	22	21.9	21.59	18.46	18.49
Working Capital	12.51	49.71	11.68	20.93	27.45
Book Value Per Share	1.52	2.91	1.06	1.77	2.59
Tangible Book Value	-9.69	63.7	22.84	32.49	47.74
Tangible Book Value Per Share	-0.44	2.91	1.06	1.76	2.58
Buildings	-	0.32	0.32	0.31	0.36
Machinery	-	1.74	1.67	1.71	1.55

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.